Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.74 EUR | +1.19% | -28.91% | -54.23% |
Apr. 30 | Bayer: strategic collaboration with Evotec | CF |
Apr. 30 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.85B | ||||||
42.19B | ||||||
42.24B | - | |||||
40.15B | ||||||
28.31B | ||||||
24.63B |
- Stock Market
- Equities
- EVT Stock
- Charts Evotec SE
- Sector Chart